Table 10.
Liver Function Before and After DEB-TACE Treatment (333 HCC DEB-TACE Records)
| Parameters | Baseline | 1 Week Post-DEB-TACE | 1-3 Months Post-DEB-TACE | p Value* | p Value† |
|---|---|---|---|---|---|
| ALB abnormal (n/%) | 132 (39.9) | 155 (54.0) | 120 (40.3) | <0.001 | 0.901 |
| TP abnormal (n/%) | 85 (25.7) | 142 (49.5) | 67 (22.5) | <0.001 | 0.332 |
| TBIL abnormal (n/%) | 88 (26.7) | 151 (52.6) | 76 (25.5) | <0.001 | 0.567 |
| TBA abnormal (n/%) | 126 (40.4) | 97 (35.7) | 116 (41.0) | 0.609 | 1.000 |
| ALT abnormal (n/%) | 70 (21.1) | 178 (62.0) | 61 (20.5) | <0.001 | 0.734 |
| AST abnormal (n/%) | 131 (39.8) | 191 (67.5) | 117 (39.4) | <0.001 | 0.494 |
| ALP abnormal (n/%) | 125 (38.2) | 120 (42.4) | 153 (51.7) | 0.105 | <0.001 |
Data are presented as count (%). Comparison among groups was determined by McNemar test. A value of p < 0.05 was considered significant. Analysis was based on 333 HCC DEB-TACE records.
*
p value of liver function-related biochemical indexes of patients from baseline to 1 week posttreatment.
†
p value of liver function-related biochemical indexes of patients from baseline to 1–3 months posttreatment.